Zeteletinib (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zeteletinib" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place

doi.org

  • Vodopivec DM, Hu MI (2022). "RET kinase inhibitors for RET-altered thyroid cancers". Therapeutic Advances in Medical Oncology. 14: 17588359221101691. doi:10.1177/17588359221101691. PMC 9218446. PMID 35756966.
  • Gou Q, Gan X, Li L, Gou Q, Zhang T (December 2022). "Precious Gene: The Application of RET-Altered Inhibitors". Molecules (Basel, Switzerland). 27 (24): 8839. doi:10.3390/molecules27248839. PMC 9784389. PMID 36557971.

nih.gov

ncbi.nlm.nih.gov

  • Vodopivec DM, Hu MI (2022). "RET kinase inhibitors for RET-altered thyroid cancers". Therapeutic Advances in Medical Oncology. 14: 17588359221101691. doi:10.1177/17588359221101691. PMC 9218446. PMID 35756966.
  • Gou Q, Gan X, Li L, Gou Q, Zhang T (December 2022). "Precious Gene: The Application of RET-Altered Inhibitors". Molecules (Basel, Switzerland). 27 (24): 8839. doi:10.3390/molecules27248839. PMC 9784389. PMID 36557971.

pubmed.ncbi.nlm.nih.gov

  • Vodopivec DM, Hu MI (2022). "RET kinase inhibitors for RET-altered thyroid cancers". Therapeutic Advances in Medical Oncology. 14: 17588359221101691. doi:10.1177/17588359221101691. PMC 9218446. PMID 35756966.
  • Gou Q, Gan X, Li L, Gou Q, Zhang T (December 2022). "Precious Gene: The Application of RET-Altered Inhibitors". Molecules (Basel, Switzerland). 27 (24): 8839. doi:10.3390/molecules27248839. PMC 9784389. PMID 36557971.